![Diagnostics | Free Full-Text | Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms Diagnostics | Free Full-Text | Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms](https://www.mdpi.com/diagnostics/diagnostics-13-03101/article_deploy/html/images/diagnostics-13-03101-g001.png)
Diagnostics | Free Full-Text | Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms
![PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bc6b05499723112efa11b692439ea1e9164a0fa/4-Table5-1.png)
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
![CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/1/465/F1.large.jpg)
CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig2_HTML.jpg)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
![PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bc6b05499723112efa11b692439ea1e9164a0fa/3-Table2-1.png)
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig2_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-019-05357-y/MediaObjects/10549_2019_5357_Fig2_HTML.png)